Fri, Aug 22, 2014, 12:49 PM EDT - U.S. Markets close in 3 hrs 11 mins


% | $
Quotes you view appear here for quick access.

BioTime, Inc. Message Board

  • btimnextmicrosoft btimnextmicrosoft Jul 18, 2013 7:17 PM Flag

    Biotime writing the textbook of next-gen biology

    West has kept his promise of providing the "picks & Shovels"

    “The sophisticated detail in the LifeMap Discovery™ database is a reflection of a movement underway in regenerative medicine toward a higher definition of cell types in research and therapy,” said Dr. Michael West, CEO of BioTime. “We believe the database will not only bring more traffic to the LifeMap database suite, but will also be the backbone for moving this increasingly complex field toward clinical application.”
    “The publication describing LifeMap Discovery™ in a leading journal in its field is a validation of the scientific merits of this leading edge state-of-the-art product,” stated David Warshawsky, Ph.D., President and CEO of LifeMap Sciences. “Our team is dedicated to continuing to enhance LifeMap Discovery™ and we are delighted to see the rapid growth of use by the global research community, already several tens of thousands of users. We are eager to see the impact that this remarkable resource will have in the transformative field of regenerative medicine.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.82-0.03(-1.05%)12:40 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.